Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis†
Open Access
- 20 April 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 43 (6) , 1267-1275
Abstract
The pituitary tumor transforming gene 1 (PTTG1) protein is cell‐cycle regulated and is identified as a human securin that inhibits sister chromatid separation and is involved in transformation and tumorigenesis. PTTG1 has very low or undetectable expression in most normal human tissues, but it is abundantly expressed in malignant cell lines and pituitary tumors. In this study, we investigated human PTTG1 expression in 62 hepatocellular carcinoma (HCC) specimens using quantitative real‐time reverse transcription polymerase chain reaction analysis. We found that, compared with corresponding noncancerous liver tissues, PTTG1 was remarkably overexpressed in HCCs (PTTG1/β‐actin; 0.443 ± 0.073 vs. 0.068 ± 0.007; P < .0001). Furthermore, we found a significant correlation between PTTG1 expression and serum alpha‐fetoprotein level (P < .001). Univariate and multivariate analyses revealed that the PTTG1 messenger RNA (mRNA) expression was an independent prognostic factor for disease‐free (odds ratio 2.70; P = .037) and overall (odds ratio 5.35; P = .007) survival. Moreover, we discovered a significant relationship between PTTG1 expression and intratumoral microvessel density. Our data supported an important role for PTTG1‐mediated upregulation of fibroblast growth factor (FGF)–2, one of angiogenesis and modulation of tumor progression, in hepatocarcinogenesis. In conclusion, PTTG1 might be critically involved in the development of HCCs through the promotion of angiogenesis. PTTG1 is overexpressed in HCC and our results suggest that PTTG1 mRNA expression has prognostic significance for the survival of postoperative patients with HCC. (HEPATOLOGY 2006.)Keywords
This publication has 29 references indexed in Scilit:
- High expression of the sister-chromatid separation regulator and proto-oncogene hSecurin occurs in a subset of myeloid leukaemias but is not implicated in the pathogenesis of aneuploidyLeukemia, 2003
- DNA Damage-induced Inhibition of Securin Expression Is Mediated by p53Journal of Biological Chemistry, 2003
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinomaHepatology, 2002
- hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTGOncogene, 1998
- Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liverHepatology, 1998
- Use of a cDNA microarray to analyse gene expression patterns in human cancerNature Genetics, 1996
- Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA MicroarrayScience, 1995
- Risk Factors Linked to Tumor Recurrence of Human Hepatocellular Carcinoma After Hepatic ResectionHepatology, 1992
- Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analysesHepatology, 1991